Literature DB >> 21686138

Application of hazard models for patients with breast cancer in Cuba.

Anet Garcia Alfonso, Néstor Arcia Montes de Oca.   

Abstract

There has been a rapid development in hazard models and survival analysis in the last decade. This article aims to assess the overall survival time of breast cancer in Cuba, as well as to determine plausible factors that may have a significant impact in the survival time. The data are obtained from the National Cancer Register of Cuba. The data set used in this study relates to 6381 patients diagnosed with breast cancer between January 2000 and December 2002. Follow-up data are available until the end of December 2007, by which time 2167 (33.9%) had died and 4214 (66.1%) were still alive. The adequacy of six parametric models is assessed by using their Akaike information criterion values. Five of the six parametric models (Exponential, Weibull, Log-logistic, Lognormal, and Generalized Gamma) are parameterized by using the accelerated failure-time metric, and the Gompertz model is parameterized by using the proportional hazard metric. The main result in terms of survival is found for the different categories of the clinical stage covariate. The survival time among patients who have been diagnosed at early stage of breast cancer is about 60% higher than the one among patients diagnosed at more advanced stage of the disease. Differences among provinces have not been found. The age is another significant factor, but there is no important difference between patient ages.

Entities:  

Keywords:  Akaike information criterion; Survival analysis; accelerated failure-time metric; proportional hazard metric

Year:  2011        PMID: 21686138      PMCID: PMC3113501     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  9 in total

1.  Developing a prognostic model in the presence of missing data: an ovarian cancer case study.

Authors:  Taane G Clark; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2003-01       Impact factor: 6.437

2.  A linear regression model for the analysis of life times.

Authors:  O O Aalen
Journal:  Stat Med       Date:  1989-08       Impact factor: 2.373

3.  Introduction to neural networks.

Authors:  S S Cross; R F Harrison; R L Kennedy
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

4.  C-erbB-2 oncoprotein overexpression identifies a subgroup of estrogen receptor positive (ER+) breast cancer patients with poor prognosis.

Authors:  A E Pinto; S André; T Pereira; S Nóbrega; J Soares
Journal:  Ann Oncol       Date:  2001-04       Impact factor: 32.976

Review 5.  Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

Authors:  P L Fitzgibbons; D L Page; D Weaver; A D Thor; D C Allred; G M Clark; S G Ruby; F O'Malley; J F Simpson; J L Connolly; D F Hayes; S B Edge; A Lichter; S J Schnitt
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

6.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

Review 7.  Survival analysis part I: basic concepts and first analyses.

Authors:  T G Clark; M J Bradburn; S B Love; D G Altman
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

Review 8.  Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit.

Authors:  M J Bradburn; T G Clark; S B Love; D G Altman
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

Review 9.  Survival analysis part II: multivariate data analysis--an introduction to concepts and methods.

Authors:  M J Bradburn; T G Clark; S B Love; D G Altman
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.